1. Home
  2. FMY vs ADVM Comparison

FMY vs ADVM Comparison

Compare FMY & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FMY
  • ADVM
  • Stock Information
  • Founded
  • FMY 2005
  • ADVM 2006
  • Country
  • FMY United States
  • ADVM United States
  • Employees
  • FMY N/A
  • ADVM N/A
  • Industry
  • FMY Finance/Investors Services
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FMY Finance
  • ADVM Health Care
  • Exchange
  • FMY Nasdaq
  • ADVM Nasdaq
  • Market Cap
  • FMY 50.6M
  • ADVM 47.4M
  • IPO Year
  • FMY N/A
  • ADVM 2014
  • Fundamental
  • Price
  • FMY $12.02
  • ADVM $2.83
  • Analyst Decision
  • FMY
  • ADVM Strong Buy
  • Analyst Count
  • FMY 0
  • ADVM 5
  • Target Price
  • FMY N/A
  • ADVM $26.40
  • AVG Volume (30 Days)
  • FMY 10.1K
  • ADVM 346.9K
  • Earning Date
  • FMY 01-01-0001
  • ADVM 05-14-2025
  • Dividend Yield
  • FMY 6.98%
  • ADVM N/A
  • EPS Growth
  • FMY N/A
  • ADVM N/A
  • EPS
  • FMY N/A
  • ADVM N/A
  • Revenue
  • FMY N/A
  • ADVM $1,000,000.00
  • Revenue This Year
  • FMY N/A
  • ADVM N/A
  • Revenue Next Year
  • FMY N/A
  • ADVM $42.58
  • P/E Ratio
  • FMY N/A
  • ADVM N/A
  • Revenue Growth
  • FMY N/A
  • ADVM N/A
  • 52 Week Low
  • FMY $10.71
  • ADVM $1.78
  • 52 Week High
  • FMY $12.17
  • ADVM $10.14
  • Technical
  • Relative Strength Index (RSI)
  • FMY 49.70
  • ADVM 55.73
  • Support Level
  • FMY $12.00
  • ADVM $2.37
  • Resistance Level
  • FMY $12.04
  • ADVM $2.63
  • Average True Range (ATR)
  • FMY 0.09
  • ADVM 0.20
  • MACD
  • FMY 0.00
  • ADVM 0.10
  • Stochastic Oscillator
  • FMY 54.29
  • ADVM 100.00

About FMY First Trust Motgage Income Fund of Beneficial Interest

First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield and maturity.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

Share on Social Networks: